Literature DB >> 31550975

Emerging role of miRNAs in renal fibrosis.

Youling Fan1,2, Hongtao Chen3, Zhenxing Huang4, Hong Zheng5, Jun Zhou6.   

Abstract

As one type of the most common endogenous short noncoding RNAs (ncRNAs), microRNAs (miRNAs) act as posttranscriptional regulators of gene expression and have great potential biological functions in the physiological and pathological processes of various diseases. The role of miRNAs in renal fibrosis has also attracted great attention in the previous 20 years, and new therapeutic strategies targeting miRNAs appear to be promising. Some researchers have previously reviewed the roles of miRNA in renal fibrosis disease, but numerous studies have emerged over the recent 5 years. It is necessary to update and summarize research progress in miRNAs in renal fibrosis. Thus, in this review, we summarize progress in miRNA-mediated renal fibrosis over the last 5 years and evaluate the biological functions of some miRNAs in different stages of renal fibrosis. Furthermore, we also expound the recent clinical applications of these miRNAs to provide new insights into the treatment of renal fibrosis disease.

Entities:  

Keywords:  Renal fibrosis; miRNA

Year:  2019        PMID: 31550975      PMCID: PMC6948964          DOI: 10.1080/15476286.2019.1667215

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  129 in total

1.  Intrarenal expression of microRNAs in patients with IgA nephropathy.

Authors:  Gang Wang; Bonnie C-H Kwan; Fernand M-M Lai; Paul C-L Choi; Kai-Ming Chow; Philip K-T Li; Cheuk-Chun Szeto
Journal:  Lab Invest       Date:  2009-11-09       Impact factor: 5.662

2.  Renal Vein Levels of MicroRNA-26a Are Lower in the Poststenotic Kidney.

Authors:  Xiang-Yang Zhu; Behzad Ebrahimi; Alfonso Eirin; John R Woollard; Hui Tang; Kyra L Jordan; Michael Ofori; Ahmed Saad; Sandra M S Herrmann; Allan B Dietz; Stephen C Textor; Amir Lerman; Lilach O Lerman
Journal:  J Am Soc Nephrol       Date:  2014-09-30       Impact factor: 10.121

Review 3.  Regulation of body growth by microRNAs.

Authors:  Julian C Lui
Journal:  Mol Cell Endocrinol       Date:  2016-10-24       Impact factor: 4.102

4.  Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease.

Authors:  Ying Shao; Huiwen Ren; Chuan Lv; Xiaoyu Ma; Can Wu; Qiuyue Wang
Journal:  Endocrine       Date:  2016-08-13       Impact factor: 3.633

5.  Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury.

Authors:  Youqun Huang; Yan Liu; Ling Li; Baihai Su; Lichuan Yang; Wenxin Fan; Qinghua Yin; Lijia Chen; Tianlei Cui; Jie Zhang; Yanrong Lu; Jingqiu Cheng; Ping Fu; Fang Liu
Journal:  BMC Nephrol       Date:  2014-09-02       Impact factor: 2.388

6.  Urinary Exosomal microRNA-451-5p Is a Potential Early Biomarker of Diabetic Nephropathy in Rats.

Authors:  Aradhana Mohan; Ravi Shankar Singh; Manju Kumari; Devika Garg; Aditya Upadhyay; Carolyn M Ecelbarger; Sucheta Tripathy; Swasti Tiwari
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

7.  Transforming growth factor-β-induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathy.

Authors:  Supriya D Deshpande; Sumanth Putta; Mei Wang; Jennifer Y Lai; Markus Bitzer; Robert G Nelson; Linda L Lanting; Mitsuo Kato; Rama Natarajan
Journal:  Diabetes       Date:  2013-05-06       Impact factor: 9.461

8.  Serum microRNAs levels in primary focal segmental glomerulosclerosis.

Authors:  Xiaoyi Cai; Zhengkun Xia; Chunni Zhang; Yang Luo; Yuanfu Gao; Zhongmin Fan; Mengyuan Liu; Ying Zhang
Journal:  Pediatr Nephrol       Date:  2013-03-06       Impact factor: 3.714

9.  MicroRNA-328 inhibits renal tubular cell epithelial-to-mesenchymal transition by targeting the CD44 in pressure-induced renal fibrosis.

Authors:  Cheng-Hsien Chen; Chung-Yi Cheng; Yen-Cheng Chen; Yuh-Mou Sue; Chung-Te Liu; Tzu-Hurng Cheng; Yung-Ho Hsu; Tso-Hsiao Chen
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

10.  MicroRNA-130b improves renal tubulointerstitial fibrosis via repression of Snail-induced epithelial-mesenchymal transition in diabetic nephropathy.

Authors:  Xiaoyan Bai; Jian Geng; Zhanmei Zhou; Jianwei Tian; Xiao Li
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

View more
  21 in total

1.  GATA1 regulates the microRNA‑328‑3p/PIM1 axis via circular RNA ITGB1 to promote renal ischemia/reperfusion injury in HK‑2 cells.

Authors:  Yang Gao; Weijia Xu; Chen Guo; Tao Huang
Journal:  Int J Mol Med       Date:  2022-06-08       Impact factor: 5.314

2.  miR‑30a‑5p mitigates autophagy by regulating the Beclin‑1/ATG16 pathway in renal ischemia/reperfusion injury.

Authors:  Ye Fang; Lin Zou; Wei He
Journal:  Int J Mol Med       Date:  2021-06-03       Impact factor: 4.101

3.  Targeting CC chemokine ligand (CCL) 20 by miR-143-5p alleviate lead poisoning-induced renal fibrosis by regulating interstitial fibroblasts excessive proliferation and dysfunction.

Authors:  Lin Han; Yanfang Zou; Chen Yu
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

4.  miR-491-5p inhibits Emilin 1 to promote fibroblasts proliferation and fibrosis in gluteal muscle contracture via TGF-Beta1/Smad2 pathway.

Authors:  Shuai Chen; Qiuwan Wu; Yang Wang; Jie Xu; Ye Wang; Xianyang Luo
Journal:  Physiol Res       Date:  2022-04-11       Impact factor: 2.139

5.  miR-155-5p Implicates in the Pathogenesis of Renal Fibrosis via Targeting SOCS1 and SOCS6.

Authors:  Wanfen Zhang; Xiaoping Li; Yushang Tang; Cheng Chen; Ran Jing; Tongqiang Liu
Journal:  Oxid Med Cell Longev       Date:  2020-06-06       Impact factor: 6.543

6.  miR-136 improves renal fibrosis in diabetic rats by targeting down-regulation of tyrosine kinase SYK and inhibition of TGF-β1/Smad3 signaling pathway.

Authors:  Lei Liu; Xinlu Pang; Wenjun Shang; Guiwen Feng; Zhigang Wang; Junxiang Wang
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

7.  Bone Marrow Mesenchymal Stem Cells Ameliorate Cisplatin-Induced Renal Fibrosis via miR-146a-5p/Tfdp2 Axis in Renal Tubular Epithelial Cells.

Authors:  Lei Wu; Chao Rong; Qing Zhou; Xin Zhao; Xue-Mei Zhuansun; Shan Wan; Mao-Min Sun; Shou-Li Wang
Journal:  Front Immunol       Date:  2021-02-16       Impact factor: 7.561

8.  An Integrated Transcriptomic Approach to Identify Molecular Markers of Calcineurin Inhibitor Nephrotoxicity in Pediatric Kidney Transplant Recipients.

Authors:  Erika T Rhone; Elissa Bardhi; Sai Vineela Bontha; Patrick D Walker; Jorge A Almenara; Catherine I Dumur; Helen Cathro; Daniel Maluf; Valeria Mas
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

Review 9.  Oligonucleotide-Based Therapies for Renal Diseases.

Authors:  Fernando Cartón-García; Cassondra Jeanette Saande; Daniel Meraviglia-Crivelli; Rafael Aldabe; Fernando Pastor
Journal:  Biomedicines       Date:  2021-03-16

Review 10.  High-Density Lipoproteins in Kidney Disease.

Authors:  Valentina Kon; Hai-Chun Yang; Loren E Smith; Kasey C Vickers; MacRae F Linton
Journal:  Int J Mol Sci       Date:  2021-07-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.